Global Cancer Biopsy Supply, Demand and Key Producers, 2023-2029

Description

The global Cancer Biopsy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.

This report studies the global Cancer Biopsy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer Biopsy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Biopsy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cancer Biopsy total market, 2018-2029, (USD Million)
Global Cancer Biopsy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cancer Biopsy total market, key domestic companies and share, (USD Million)
Global Cancer Biopsy revenue by player and market share 2018-2023, (USD Million)
Global Cancer Biopsy total market by Type, CAGR, 2018-2029, (USD Million)
Global Cancer Biopsy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cancer Biopsy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher and Lucence Diagnostics Pte. Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Biopsy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cancer Biopsy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cancer Biopsy Market, Segmentation by Type
    Tissue Biopsies
    Liquid Biopsies
    Others

Global Cancer Biopsy Market, Segmentation by Application
    Breast Cancer
    Colorectal Cancer
    Cervical Cancers
    Lung Cancers
    Prostate Cancers
    Skin Cancers
    Blood Cancers
    Kidney Cancers
    Others

Companies Profiled:
    Qiagen N.V.
    Illumina, Inc.
    ANGLE Plc
    Myriad Genetics
    Hologic, Inc.
    Biocept, Inc.
    Thermo Fisher Scientific, Inc.
    Danaher
    Lucence Diagnostics Pte. Ltd.
    GRAIL, Inc.
    Guardant Health
    Exact Sciences Corporation
    Freenome Holdings, Inc.
    Oncimmune
    Chronix Biomedical, Inc.
    Personal Genome Diagnostics Inc.

Key Questions Answered
1. How big is the global Cancer Biopsy market?
2. What is the demand of the global Cancer Biopsy market?
3. What is the year over year growth of the global Cancer Biopsy market?
4. What is the total value of the global Cancer Biopsy market?
5. Who are the major players in the global Cancer Biopsy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cancer Biopsy Introduction
    1.2 World Cancer Biopsy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Cancer Biopsy Total Market by Region (by Headquarter Location)
        1.3.1 World Cancer Biopsy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Cancer Biopsy Market Size (2018-2029)
        1.3.3 China Cancer Biopsy Market Size (2018-2029)
        1.3.4 Europe Cancer Biopsy Market Size (2018-2029)
        1.3.5 Japan Cancer Biopsy Market Size (2018-2029)
        1.3.6 South Korea Cancer Biopsy Market Size (2018-2029)
        1.3.7 ASEAN Cancer Biopsy Market Size (2018-2029)
        1.3.8 India Cancer Biopsy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cancer Biopsy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cancer Biopsy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cancer Biopsy Consumption Value (2018-2029)
    2.2 World Cancer Biopsy Consumption Value by Region
        2.2.1 World Cancer Biopsy Consumption Value by Region (2018-2023)
        2.2.2 World Cancer Biopsy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Cancer Biopsy Consumption Value (2018-2029)
    2.4 China Cancer Biopsy Consumption Value (2018-2029)
    2.5 Europe Cancer Biopsy Consumption Value (2018-2029)
    2.6 Japan Cancer Biopsy Consumption Value (2018-2029)
    2.7 South Korea Cancer Biopsy Consumption Value (2018-2029)
    2.8 ASEAN Cancer Biopsy Consumption Value (2018-2029)
    2.9 India Cancer Biopsy Consumption Value (2018-2029)

3 World Cancer Biopsy Companies Competitive Analysis
    3.1 World Cancer Biopsy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cancer Biopsy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cancer Biopsy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Cancer Biopsy in 2022
    3.3 Cancer Biopsy Company Evaluation Quadrant
    3.4 Cancer Biopsy Market: Overall Company Footprint Analysis
        3.4.1 Cancer Biopsy Market: Region Footprint
        3.4.2 Cancer Biopsy Market: Company Product Type Footprint
        3.4.3 Cancer Biopsy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cancer Biopsy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cancer Biopsy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Cancer Biopsy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Cancer Biopsy Consumption Value Comparison
        4.2.1 United States VS China: Cancer Biopsy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cancer Biopsy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Cancer Biopsy Companies and Market Share, 2018-2023
        4.3.1 United States Based Cancer Biopsy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cancer Biopsy Revenue, (2018-2023)
    4.4 China Based Companies Cancer Biopsy Revenue and Market Share, 2018-2023
        4.4.1 China Based Cancer Biopsy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cancer Biopsy Revenue, (2018-2023)
    4.5 Rest of World Based Cancer Biopsy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Cancer Biopsy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cancer Biopsy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Cancer Biopsy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Tissue Biopsies
        5.2.2 Liquid Biopsies
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Cancer Biopsy Market Size by Type (2018-2023)
        5.3.2 World Cancer Biopsy Market Size by Type (2024-2029)
        5.3.3 World Cancer Biopsy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cancer Biopsy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Breast Cancer
        6.2.2 Colorectal Cancer
        6.2.3 Cervical Cancers
        6.2.4 Lung Cancers
        6.2.5 Lung Cancers
        6.2.6 Skin Cancers
        6.2.7 Blood Cancers
        6.2.8 Kidney Cancers
        6.2.9 Others
    6.3 Market Segment by Application
        6.3.1 World Cancer Biopsy Market Size by Application (2018-2023)
        6.3.2 World Cancer Biopsy Market Size by Application (2024-2029)
        6.3.3 World Cancer Biopsy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Qiagen N.V.
        7.1.1 Qiagen N.V. Details
        7.1.2 Qiagen N.V. Major Business
        7.1.3 Qiagen N.V. Cancer Biopsy Product and Services
        7.1.4 Qiagen N.V. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Qiagen N.V. Recent Developments/Updates
        7.1.6 Qiagen N.V. Competitive Strengths & Weaknesses
    7.2 Illumina, Inc.
        7.2.1 Illumina, Inc. Details
        7.2.2 Illumina, Inc. Major Business
        7.2.3 Illumina, Inc. Cancer Biopsy Product and Services
        7.2.4 Illumina, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Illumina, Inc. Recent Developments/Updates
        7.2.6 Illumina, Inc. Competitive Strengths & Weaknesses
    7.3 ANGLE Plc
        7.3.1 ANGLE Plc Details
        7.3.2 ANGLE Plc Major Business
        7.3.3 ANGLE Plc Cancer Biopsy Product and Services
        7.3.4 ANGLE Plc Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 ANGLE Plc Recent Developments/Updates
        7.3.6 ANGLE Plc Competitive Strengths & Weaknesses
    7.4 Myriad Genetics
        7.4.1 Myriad Genetics Details
        7.4.2 Myriad Genetics Major Business
        7.4.3 Myriad Genetics Cancer Biopsy Product and Services
        7.4.4 Myriad Genetics Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Myriad Genetics Recent Developments/Updates
        7.4.6 Myriad Genetics Competitive Strengths & Weaknesses
    7.5 Hologic, Inc.
        7.5.1 Hologic, Inc. Details
        7.5.2 Hologic, Inc. Major Business
        7.5.3 Hologic, Inc. Cancer Biopsy Product and Services
        7.5.4 Hologic, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Hologic, Inc. Recent Developments/Updates
        7.5.6 Hologic, Inc. Competitive Strengths & Weaknesses
    7.6 Biocept, Inc.
        7.6.1 Biocept, Inc. Details
        7.6.2 Biocept, Inc. Major Business
        7.6.3 Biocept, Inc. Cancer Biopsy Product and Services
        7.6.4 Biocept, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Biocept, Inc. Recent Developments/Updates
        7.6.6 Biocept, Inc. Competitive Strengths & Weaknesses
    7.7 Thermo Fisher Scientific, Inc.
        7.7.1 Thermo Fisher Scientific, Inc. Details
        7.7.2 Thermo Fisher Scientific, Inc. Major Business
        7.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Product and Services
        7.7.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
        7.7.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
    7.8 Danaher
        7.8.1 Danaher Details
        7.8.2 Danaher Major Business
        7.8.3 Danaher Cancer Biopsy Product and Services
        7.8.4 Danaher Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Danaher Recent Developments/Updates
        7.8.6 Danaher Competitive Strengths & Weaknesses
    7.9 Lucence Diagnostics Pte. Ltd.
        7.9.1 Lucence Diagnostics Pte. Ltd. Details
        7.9.2 Lucence Diagnostics Pte. Ltd. Major Business
        7.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product and Services
        7.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments/Updates
        7.9.6 Lucence Diagnostics Pte. Ltd. Competitive Strengths & Weaknesses
    7.10 GRAIL, Inc.
        7.10.1 GRAIL, Inc. Details
        7.10.2 GRAIL, Inc. Major Business
        7.10.3 GRAIL, Inc. Cancer Biopsy Product and Services
        7.10.4 GRAIL, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 GRAIL, Inc. Recent Developments/Updates
        7.10.6 GRAIL, Inc. Competitive Strengths & Weaknesses
    7.11 Guardant Health
        7.11.1 Guardant Health Details
        7.11.2 Guardant Health Major Business
        7.11.3 Guardant Health Cancer Biopsy Product and Services
        7.11.4 Guardant Health Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Guardant Health Recent Developments/Updates
        7.11.6 Guardant Health Competitive Strengths & Weaknesses
    7.12 Exact Sciences Corporation
        7.12.1 Exact Sciences Corporation Details
        7.12.2 Exact Sciences Corporation Major Business
        7.12.3 Exact Sciences Corporation Cancer Biopsy Product and Services
        7.12.4 Exact Sciences Corporation Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Exact Sciences Corporation Recent Developments/Updates
        7.12.6 Exact Sciences Corporation Competitive Strengths & Weaknesses
    7.13 Freenome Holdings, Inc.
        7.13.1 Freenome Holdings, Inc. Details
        7.13.2 Freenome Holdings, Inc. Major Business
        7.13.3 Freenome Holdings, Inc. Cancer Biopsy Product and Services
        7.13.4 Freenome Holdings, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Freenome Holdings, Inc. Recent Developments/Updates
        7.13.6 Freenome Holdings, Inc. Competitive Strengths & Weaknesses
    7.14 Oncimmune
        7.14.1 Oncimmune Details
        7.14.2 Oncimmune Major Business
        7.14.3 Oncimmune Cancer Biopsy Product and Services
        7.14.4 Oncimmune Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Oncimmune Recent Developments/Updates
        7.14.6 Oncimmune Competitive Strengths & Weaknesses
    7.15 Chronix Biomedical, Inc.
        7.15.1 Chronix Biomedical, Inc. Details
        7.15.2 Chronix Biomedical, Inc. Major Business
        7.15.3 Chronix Biomedical, Inc. Cancer Biopsy Product and Services
        7.15.4 Chronix Biomedical, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Chronix Biomedical, Inc. Recent Developments/Updates
        7.15.6 Chronix Biomedical, Inc. Competitive Strengths & Weaknesses
    7.16 Personal Genome Diagnostics Inc.
        7.16.1 Personal Genome Diagnostics Inc. Details
        7.16.2 Personal Genome Diagnostics Inc. Major Business
        7.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Product and Services
        7.16.4 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Personal Genome Diagnostics Inc. Recent Developments/Updates
        7.16.6 Personal Genome Diagnostics Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cancer Biopsy Industry Chain
    8.2 Cancer Biopsy Upstream Analysis
    8.3 Cancer Biopsy Midstream Analysis
    8.4 Cancer Biopsy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cancer Biopsy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Cancer Biopsy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Cancer Biopsy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Cancer Biopsy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Cancer Biopsy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cancer Biopsy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Cancer Biopsy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Cancer Biopsy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Cancer Biopsy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Cancer Biopsy Players in 2022
    Table 12. World Cancer Biopsy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Cancer Biopsy Company Evaluation Quadrant
    Table 14. Head Office of Key Cancer Biopsy Player
    Table 15. Cancer Biopsy Market: Company Product Type Footprint
    Table 16. Cancer Biopsy Market: Company Product Application Footprint
    Table 17. Cancer Biopsy Mergers & Acquisitions Activity
    Table 18. United States VS China Cancer Biopsy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Cancer Biopsy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Cancer Biopsy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cancer Biopsy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Cancer Biopsy Revenue Market Share (2018-2023)
    Table 23. China Based Cancer Biopsy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cancer Biopsy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Cancer Biopsy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Cancer Biopsy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cancer Biopsy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Cancer Biopsy Revenue Market Share (2018-2023)
    Table 29. World Cancer Biopsy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Cancer Biopsy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Cancer Biopsy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Cancer Biopsy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Cancer Biopsy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Cancer Biopsy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Qiagen N.V. Basic Information, Area Served and Competitors
    Table 36. Qiagen N.V. Major Business
    Table 37. Qiagen N.V. Cancer Biopsy Product and Services
    Table 38. Qiagen N.V. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Qiagen N.V. Recent Developments/Updates
    Table 40. Qiagen N.V. Competitive Strengths & Weaknesses
    Table 41. Illumina, Inc. Basic Information, Area Served and Competitors
    Table 42. Illumina, Inc. Major Business
    Table 43. Illumina, Inc. Cancer Biopsy Product and Services
    Table 44. Illumina, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Illumina, Inc. Recent Developments/Updates
    Table 46. Illumina, Inc. Competitive Strengths & Weaknesses
    Table 47. ANGLE Plc Basic Information, Area Served and Competitors
    Table 48. ANGLE Plc Major Business
    Table 49. ANGLE Plc Cancer Biopsy Product and Services
    Table 50. ANGLE Plc Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. ANGLE Plc Recent Developments/Updates
    Table 52. ANGLE Plc Competitive Strengths & Weaknesses
    Table 53. Myriad Genetics Basic Information, Area Served and Competitors
    Table 54. Myriad Genetics Major Business
    Table 55. Myriad Genetics Cancer Biopsy Product and Services
    Table 56. Myriad Genetics Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Myriad Genetics Recent Developments/Updates
    Table 58. Myriad Genetics Competitive Strengths & Weaknesses
    Table 59. Hologic, Inc. Basic Information, Area Served and Competitors
    Table 60. Hologic, Inc. Major Business
    Table 61. Hologic, Inc. Cancer Biopsy Product and Services
    Table 62. Hologic, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Hologic, Inc. Recent Developments/Updates
    Table 64. Hologic, Inc. Competitive Strengths & Weaknesses
    Table 65. Biocept, Inc. Basic Information, Area Served and Competitors
    Table 66. Biocept, Inc. Major Business
    Table 67. Biocept, Inc. Cancer Biopsy Product and Services
    Table 68. Biocept, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Biocept, Inc. Recent Developments/Updates
    Table 70. Biocept, Inc. Competitive Strengths & Weaknesses
    Table 71. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
    Table 72. Thermo Fisher Scientific, Inc. Major Business
    Table 73. Thermo Fisher Scientific, Inc. Cancer Biopsy Product and Services
    Table 74. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Thermo Fisher Scientific, Inc. Recent Developments/Updates
    Table 76. Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
    Table 77. Danaher Basic Information, Area Served and Competitors
    Table 78. Danaher Major Business
    Table 79. Danaher Cancer Biopsy Product and Services
    Table 80. Danaher Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Danaher Recent Developments/Updates
    Table 82. Danaher Competitive Strengths & Weaknesses
    Table 83. Lucence Diagnostics Pte. Ltd. Basic Information, Area Served and Competitors
    Table 84. Lucence Diagnostics Pte. Ltd. Major Business
    Table 85. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product and Services
    Table 86. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Lucence Diagnostics Pte. Ltd. Recent Developments/Updates
    Table 88. Lucence Diagnostics Pte. Ltd. Competitive Strengths & Weaknesses
    Table 89. GRAIL, Inc. Basic Information, Area Served and Competitors
    Table 90. GRAIL, Inc. Major Business
    Table 91. GRAIL, Inc. Cancer Biopsy Product and Services
    Table 92. GRAIL, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. GRAIL, Inc. Recent Developments/Updates
    Table 94. GRAIL, Inc. Competitive Strengths & Weaknesses
    Table 95. Guardant Health Basic Information, Area Served and Competitors
    Table 96. Guardant Health Major Business
    Table 97. Guardant Health Cancer Biopsy Product and Services
    Table 98. Guardant Health Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Guardant Health Recent Developments/Updates
    Table 100. Guardant Health Competitive Strengths & Weaknesses
    Table 101. Exact Sciences Corporation Basic Information, Area Served and Competitors
    Table 102. Exact Sciences Corporation Major Business
    Table 103. Exact Sciences Corporation Cancer Biopsy Product and Services
    Table 104. Exact Sciences Corporation Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Exact Sciences Corporation Recent Developments/Updates
    Table 106. Exact Sciences Corporation Competitive Strengths & Weaknesses
    Table 107. Freenome Holdings, Inc. Basic Information, Area Served and Competitors
    Table 108. Freenome Holdings, Inc. Major Business
    Table 109. Freenome Holdings, Inc. Cancer Biopsy Product and Services
    Table 110. Freenome Holdings, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Freenome Holdings, Inc. Recent Developments/Updates
    Table 112. Freenome Holdings, Inc. Competitive Strengths & Weaknesses
    Table 113. Oncimmune Basic Information, Area Served and Competitors
    Table 114. Oncimmune Major Business
    Table 115. Oncimmune Cancer Biopsy Product and Services
    Table 116. Oncimmune Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Oncimmune Recent Developments/Updates
    Table 118. Oncimmune Competitive Strengths & Weaknesses
    Table 119. Chronix Biomedical, Inc. Basic Information, Area Served and Competitors
    Table 120. Chronix Biomedical, Inc. Major Business
    Table 121. Chronix Biomedical, Inc. Cancer Biopsy Product and Services
    Table 122. Chronix Biomedical, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Chronix Biomedical, Inc. Recent Developments/Updates
    Table 124. Personal Genome Diagnostics Inc. Basic Information, Area Served and Competitors
    Table 125. Personal Genome Diagnostics Inc. Major Business
    Table 126. Personal Genome Diagnostics Inc. Cancer Biopsy Product and Services
    Table 127. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 128. Global Key Players of Cancer Biopsy Upstream (Raw Materials)
    Table 129. Cancer Biopsy Typical Customers
List of Figure
    Figure 1. Cancer Biopsy Picture
    Figure 2. World Cancer Biopsy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cancer Biopsy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Cancer Biopsy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cancer Biopsy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Cancer Biopsy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Cancer Biopsy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Cancer Biopsy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Cancer Biopsy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Cancer Biopsy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Cancer Biopsy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Cancer Biopsy Revenue (2018-2029) & (USD Million)
    Figure 13. Cancer Biopsy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Cancer Biopsy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Cancer Biopsy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Biopsy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Biopsy Markets in 2022
    Figure 27. United States VS China: Cancer Biopsy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cancer Biopsy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Cancer Biopsy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Cancer Biopsy Market Size Market Share by Type in 2022
    Figure 31. Tissue Biopsies
    Figure 32. Liquid Biopsies
    Figure 33. Others
    Figure 34. World Cancer Biopsy Market Size Market Share by Type (2018-2029)
    Figure 35. World Cancer Biopsy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Cancer Biopsy Market Size Market Share by Application in 2022
    Figure 37. Breast Cancer
    Figure 38. Colorectal Cancer
    Figure 39. Cervical Cancers
    Figure 40. Lung Cancers
    Figure 41. Prostate Cancers
    Figure 42. Skin Cancers
    Figure 43. Blood Cancers
    Figure 44. Kidney Cancers
    Figure 45. Others
    Figure 46. Cancer Biopsy Industrial Chain
    Figure 47. Methodology
    Figure 48. Research Process and Data Source

Companies Mentioned

Qiagen N.V.
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Biocept, Inc.
Thermo Fisher Scientific, Inc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics Inc.